Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A discrete choice experiment

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Mühlbacher, Axel C ^a,b   Rudolph, Ina ^c   Lincke, Hans Joachim ^a   Nübling, Matthias ^a  

^a GEB MbH Empirical Consulting   (Germany)

^b Hochschule Neubrandenburg   (Germany)

^c JANSSEN CILAG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTENT VALIDITY; DECISION MAKING; EMOTION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; TREATMENT OUTCOME; HEALTH SERVICE; INFANT; INTERVIEW; MIDDLE AGED; PARENT; PATIENT SATISFACTION; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; CHOICE BEHAVIOR; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFANT; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PARENTS; PATIENT SATISFACTION; QUESTIONNAIRES; YOUNG ADULT;

EID: 69549135663     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-149     Document Type: Article

References (20)

1. Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study. PM Wehmeier RW Dittmann A Schacht A Minarzyk M Lehmann K Sevecke G Lehmkuhl, J Child Adolesc Psychopharmacol 2007 17 6 813 30 10.1089/cap.2007.0025 18315453 (Pubitemid 351158598)
2. Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS-MPH) results from an open-label naturalistic study. C Mitt W Arend B Schauble L Hargarter F Mattejat, European Psychiatry 2008 23 S2 S394 10.1016/j.eurpsy.2008.01.1364
3. Children's Self-Reports on Perceived Effects on Taking Stimulant Medication for ADHD. LB Thorell K Dahlström, J Atten Disord 2009 12 5 460 468 10.1177/1087054708320430 18685139
4. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. G Polanczyk MS de Lima BL Horta J Biederman LA Rhode, Am J Psychiatry 2007 164 942 948 10.1176/appi.ajp.164.6.942 17541055 (Pubitemid 46972911)
5. Attention deficit/hyperactivity disorder across the lifespan. TE Wilens J Biederman TJ Spencer, Annu Rev Med 2002 53 113 31 10.1146/annurev.med.53. 082901.103945 11818466 (Pubitemid 34177874)
6. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. TE Brown, American Psychiatric Press, Inc., Washington 2000
7. Young adult outcome of hyperactive children: adaptive functioning in major life activities. RA Barkley M Fischer L Smallish K Fletcher, J Am Acad Child Adolesc Psychiatry 2006 45 2 192 202 10.1097/01.chi.0000189134.97436.e2 16429090 (Pubitemid 43151524)
8. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. RT Brown RW Amler WS Freeman JM Perrin MT Stein HM Feldman K Pierce ML Wolraich the Committee on Quality Improvement, Pediatrics 2005 115 6 e749 57 10.1542/peds.2004-2560 15930203 (Pubitemid 43843150)
9. Psychopharmaka. MJ Lohse B Müller-Oerlinghausen, Arzneiverordnungsreport Springer Medizin Verlag, Heidelberg, Schwabe U, Paffrath, 2008
10. European clinical guidelines for hyperkinetic disorder first upgrade. E Taylor M Döpfner J Sergeant P Asherson T Banaschewski J Buitelaar D Coghill M Danckaerts A Rothenberger E Sonuga-Barke HC Steinhausen A Zuddas, Eur Child Adolesc Psychiatry 2004 13 1 17 30 10.1007/s00787-004-1002-x (Pubitemid 39172160)
11. Conditional Logit Analysis of Qualitative Choice Behavior. D McFadden, Frontiers in Econometrics New York Academic Press, Zarembka P, 1974 105 142
12. Nutzenmessung im Gesundheitswesen: Die Methode der Discrete- Choice-Experimente (Utility Measurement in Health: The Method of Discrete Choice Experiments). H Telser, Hamburg, Verlag Dr. Kovac (Schriftenreihe volkswirtschaftliche Forschungsergebnisse Bd. 78) 2002
13. Using Discrete Choice Experiments to Value Health and Health Care, The Economics of Non-Market Goods and Resources. M Ryan K Gerard M Amaya-Amaya Eds, Dordrecht, Springer 2008 11
14. Conducting Discrete Choice Experiments to Inform Health Care Decision Making: A User's Guide, 2008. E Lancsar J Louviere, Pharmacoeconomics 2008 26 8 661 677 10.2165/00019053-200826080-00004 18620460 (Pubitemid 351989058)
15. Several methods to investigate relative attribute impact in stated preference experiments. E Lancsar JJ Louviere TN Flynn, Social Science and Medicine 2007 64 1738 1753 10.1016/j.socscimed.2006.12.007 17257725 (Pubitemid 46436252)
16. Discrete Choice Analysis. M Ben-Akiva SR Lerman, Cambridge, Mass: MIT Press 1985
17. Best-Worst Scaling: What it can do for health care research and how to do it. TN Flynn JJ Louviere TJ Peters J Coast, Journal of Health Economics 2007 26 1 171 89 10.1016/j.jhealeco.2006.04.002 16707175 (Pubitemid 44908719)
18. Discrete Choice Experiments [computer software]. L Burgess, Department of Mathematical Sciences, University of Technology, Sydney 2007 http://crsu.science.uts.edu.au/choice/
19. Response styles in marketing research: a cross-national investigation. H Baumgartner J-BEM Steenkamp, J Marketing Res 2001 38 2 143 156 10.1509/jmkr.38.2.143.18840
20. Crossing the quality chasm: a new health system for the 21st century. The Institute of Medicine, Washington DC, National Academy Press 2001